Korean J Gastroenterol.  2010 Mar;55(3):208-210. 10.4166/kjg.2010.55.3.208.

Is Clostridium difficile Infection Increasing in Korea?

Affiliations
  • 1Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea. hands@hanyang.ac.kr

Abstract

No abstract available.


MeSH Terms

Anti-Bacterial Agents/therapeutic use
*Clostridium difficile
Enterocolitis, Pseudomembranous/drug therapy/*epidemiology
Humans
Republic of Korea/epidemiology

Cited by  1 articles

Epidemiology and Clinical Characteristics of Clostridium difficile-associated Disease in Children: Comparison between Community- and Hospital-acquired Infections
Hye Jung Cho, Eell Ryoo, Yong Han Sun, Kang Ho Cho, Dong Woo Son, Hann Tchah
Korean J Pediatr Gastroenterol Nutr. 2010;13(2):146-153.    doi: 10.5223/kjpgn.2010.13.2.146.


Reference

1. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotics associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med. 1978; 298:531–534.
2. Ricciardi R, Rothenbeger DA, Mandoff RD, Baxter NN. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg. 2007; 142:624–631.
3. Pé pin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMA J. 2005; 173:1037–1042.
4. Kuijper EJ, van Dissel JT, Wilcox MH. Clostridium difficile: changing epidemiology and new treatment options. Curr Opin Infect Dis. 2007; 20:376–383.
5. Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN. A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother. 2008; 62:388–396.
6. Tae CH, Jung SA, Song HJ, et al. The first case of anti-biotic-associated colitis by Clostridium difficile PCR ribotype 027 in Korea. J Korean Med Sci. 2009; 24:520–524.
7. Lee YJ, Choi MG, Lim CH, et al. Change of Clostridium difficile colitis during recent 10 years in Korea. Korean J Gastroenterol. 2010; 55:169–174.
8. Lee JH, Lee SY, Kim YS, et al. The incidence and clinical features of Clostridium difficile-infection; single center study. Korean J Gastroenterol. 2010; 55:175–182.
9. Byun TJ, Han DS, Ahn SB, et al. Clinical characteristics and changing epidemiology of Clostiridium difficile-associated dia-sease (CDAD). Korean J Gastroenterol. 2009; 54:13–19.
10. Monaghan T, Boswell T, Mahida YR. Recent advances in Clostridium difficile-associated disease. Gut. 2008; 57:850–860.
11. Park HS, Han DS. Management of antibiotics-associated diarrhea. Korean J Gastroenterol. 2009; 54:5–12.
Article
12. Leffler DA, Lamont JT. Treatment of Clostridium difficile-associated disease. Gastroenterology. 2009; 136:1899–1912.
13. Gerding DN, Muto CA, Owens RC Jr. Treatment of Clostridium difficile infection. Clin infect Dis. 2008; 46(suppl 1):S32–42.
14. Surawicz CM. Reining in recurrent Clostridium difficile infection–who's at risk? Gastroenterology. 2009; 136:1152–1154.
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr